Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ECALLANTIDE vs EFAVIRENZ: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ECALLANTIDE vs EFAVIRENZ: Safety Overview

Metric ECALLANTIDE EFAVIRENZ
Total FAERS Reports 1,206 7,893
Deaths Reported 23 962
Death Rate 1.9% 12.2%
Hospitalizations 499 1,528
Average Patient Age 42.9 yrs 40.7 yrs
% Female Patients 84.1% 37.7%
FDA Approval Date N/A Apr 27, 2018
Manufacturer Takeda Pharmaceuticals America, Inc. Camber Pharmaceuticals, Inc.
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Discontinued